INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 88 filers reported holding INSMED INC in Q3 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $35,794,000 | +3.0% | 2,705,488 | +13.1% | 0.01% | 0.0% |
| Q3 2016 | $34,745,000 | +55.3% | 2,392,925 | +5.5% | 0.01% | +40.0% |
| Q2 2016 | $22,368,000 | -22.9% | 2,268,606 | -1.0% | 0.01% | -28.6% |
| Q1 2016 | $29,029,000 | -28.9% | 2,291,187 | +1.8% | 0.01% | -22.2% |
| Q4 2015 | $40,837,000 | -6.2% | 2,249,994 | -4.0% | 0.01% | -18.2% |
| Q3 2015 | $43,542,000 | -21.3% | 2,344,745 | +3.5% | 0.01% | -15.4% |
| Q2 2015 | $55,348,000 | +32.0% | 2,266,502 | +12.4% | 0.01% | +30.0% |
| Q1 2015 | $41,943,000 | +38.4% | 2,016,513 | +2.9% | 0.01% | +42.9% |
| Q4 2014 | $30,309,000 | +97.2% | 1,959,185 | +66.4% | 0.01% | +75.0% |
| Q3 2014 | $15,366,000 | -21.0% | 1,177,493 | +20.9% | 0.00% | -20.0% |
| Q2 2014 | $19,452,000 | +5.2% | 973,573 | +0.3% | 0.01% | 0.0% |
| Q1 2014 | $18,482,000 | +15.2% | 970,670 | +2.9% | 0.01% | 0.0% |
| Q4 2013 | $16,037,000 | +4.9% | 943,342 | -3.7% | 0.01% | 0.0% |
| Q3 2013 | $15,291,000 | +81.3% | 979,585 | +38.9% | 0.01% | +66.7% |
| Q2 2013 | $8,433,000 | – | 705,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |